A genetically tractable model of human glioma formation.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11325817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reconstituted basement membrane (matrigel) enhances the growth of human glioma cell lines in nude mice

  2004cited by this paper
• Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

  2001cited by this paper
• Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

  2000cited by this paper
• Cell biology: Risky immortalization by telomerase

  2000cited by this paper
• Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

  2000cited by this paper
• Risky immortalization by telomerase

  2000cited by this paper
• Molecular pathogenesis of malignant gliomas.

  1999cited by this paper
• Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.

  1999cited by this paper
• Progression as exemplified by human astrocytic tumors.

  1999cited by this paper
• Cell and molecular biology of simian virus 40: implications for human infections and disease.

  1999cited by this paper
• Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

  1999cited by this paper
• Modulation of the immune response and tumor growth by activated Ras

  1999cited by this paper
• Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.

  1999cited by this paper
• Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors

  1999cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen

  1999cited by this paper
• Brain tumor survival: Results from the National Cancer Data Base

  1998cited by this paper
• Reversing time: origin of telomerase.

  1998cited by this paper
• Telomerase activity in 144 brain tumours.

  1998cited by this paper
• Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

  1998cited by this paper
• Mechanisms of altered growth control. Growth factors

  1998cited by this paper
• Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)

  1997cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Stepwise transformation of astrocytes by simian virus 40 large T antigen and epidermal growth factor receptor overexpression.

  1996cited by this paper
• Detecting activations in PET and fMRI: levels of inference and power.

  1996cited by this paper
• The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.

  1994cited by this paper
• Book reviewTransformation assay of established cell lines: Mechanisms and application: Edited by T. Kakunaga and H. Yamasaki. Oxford University Press for the International Agency for Research on Cancer (No. 67), 1986. Pp. 225. ISBN 92 832 1167 7. Price: £20.00

  1986cited by this paper
• Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes

  1986cited by this paper
• Anaplastic human gliomas grown in athymic mice. Morphology and glial fibrillary acidic protein expression.

  1981cited by this paper

• Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs

  2024cites this paper
• TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro

  2023cites this paper
• Autologous humanized mouse models of iPSC-derived tumors enable characterization and modulation of cancer-immune cell interactions

  2022cites this paper
• Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma.

  2022cites this paper
• Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets.

  2021cites this paper
• Role of neutrophil-lymphocyte ratio as a predictive factor of glioma tumor grade: a systematic review.

  2021cites this paper
• Autologous humanized mouse models of iPSC-derived tumors allow for the evaluation and modulation of cancer-immune cell interactions

  2021cites this paper
• Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism

  2020cites this paper
• Genome Engineering Evolves Brain Tumor Modeling

  2020cites this paper
• Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells

  2020cites this paper
• Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of leukemia

  2020cites this paper
• Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.

  2019cites this paper
• Investigation of epigenetic regulators important for tumour initiation and maintenance

  2019cites this paper
• Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

  2019cites this paper
• Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence.

  2019cites this paper
• Glioblastomas derived from genetically modified pluripotent stem cells recapitulate pathobiology

  2019cites this paper
• Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype

  2018cites this paper
• Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management

  2017cites this paper
• NOS Expression and NO Function in Glioma and Implications for Patient Therapies

  2017cites this paper
• Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model

  2017cites this paper
• Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors.

  2016cites this paper
• Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.

  2016influential citation
• Control of stress signaling in stem cells: crossroads of stem cells and cancer

  2016cites this paper
• Telomeres and telomerase and their functional applications in myeloproliferative neoplasms and acute myeloid leukemia

  2016cites this paper
• The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity

  2016cites this paper
• The renewed battle against RAS-mutant cancers

  2016cites this paper
• Integration of RNA and protein expression profiles to study human cells

  2016cites this paper
• miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis

  2016cites this paper
• Glioma: an overview of current classifications, characteristics, molecular biology and target therapies.

  2015cites this paper
• Contemporary murine models in preclinical astrocytoma drug development.

  2015cites this paper
• SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.

  2015cites this paper
• Modelling the multi-step process of tumorigenesis in pigs

  2015cites this paper
• Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice.

  2014cites this paper
• Molecular biology of gliomas: present and future challenges

  2014cites this paper
• Fonctions antitumorales de la voie ERK/MAPK et développement rationnel de nouvelles stratégies thérapeutiques

  2014cites this paper
• The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

  2013cites this paper
• The regulation of mitochondrial DNA copy number in glioblastoma cells

  2013cites this paper
• Suppression of Cellular Senescence in Glioblastoma: Role of Src Homology Domain-Containing Phosphatase 2

  2013cites this paper
• Generation of Cancerous Neural Stem Cells Forming Glial Tumor by Oncogenic Stimulation

  2012influential citation
• Off‐Telomere Functions of Telomerase

  2012cites this paper
• iTRAQ analysis of a cell culture model for malignant transformation, including comparison with 2D-PAGE and SILAC.

  2012cites this paper
• Oncogenic challenges in stem cells and the link to cancer initiation

  2012cites this paper
• Oncogenic challenges in stem cells and the link to cancer initiation

  2012cites this paper
• MicroRNA-146a Inhibits Glioma Development by Targeting Notch1

  2011cites this paper
• THE MECHANISM OF TUMORIGENESIS IN THE IMMORTALIZED HUMAN PANCREATIC CELL LINES: CELL CULTURE MODELS OF HUMAN PANCREATIC CANCER

  2011cites this paper
• Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System

  2011cites this paper
• EGFR overexpression induces activation of telomerase via PI3K/AKT‐mediated phosphorylation and transcriptional regulation through Hif1‐alpha in a cellular model of oral–esophageal carcinogenesis

  2011cites this paper
• MicroRNA-146 a Inhibits Glioma Development by Targeting Notch 1

  2011cites this paper
• Src homology domain-containing phosphatase 2 suppresses cellular senescence in glioblastoma

  2011cites this paper
• Cellular Origins of Malignant Glioma: The Cancer Stem Cell Polemic

  2011cites this paper
• Integration and analysis of genome-scale data from gliomas

  2011cites this paper
• Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival

  2011cites this paper
• Animal models to study cancer-initiating cells from glioblastoma.

  2011cites this paper
• The role of neural stem cells in tumourigenesis of the central nervous system

  2011cites this paper
• Clinical significance of astrocyte elevated gene-1 expression in human oligodendrogliomas.

  2010cites this paper
• Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition

  2010cites this paper
• FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.

  2010cites this paper
• Gliomagenesis and the use of neural stem cells in brain tumor treatment.

  2010cites this paper
• Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE

  2010cites this paper
• Can be Safely Targeted for Telomerase Inhibition Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance

  2010cites this paper
• Cell‐context specific role of the E2F/Rb pathway in development and disease

  2009cites this paper
• Brain Tumor Stem Cells

  2009cites this paper
• Ovarian cancer: pathology, biology, and disease models.

  2009cites this paper
• Transformed Human Brain Cells in Culture as a Model for Brain Tumors

  2009cites this paper
• Molecular Targets for Antibody-Mediated Immunotherapy of Malignant Glioma

  2009cites this paper
• The role of anchorage in cell cycle control

  2009cites this paper
• Molecular Basis of Human Malignancy

  2009cites this paper
• Origins and clinical implications of the brain tumor stem cell hypothesis

  2009cites this paper
• Genetically transforming human mesenchymal stem cells to sarcomas

  2009cites this paper
• Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling

  2008cites this paper
• Effects of dysregulated YB-1 expression on the oncogenesis of pediatric glioblastoma

  2008cites this paper
• Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes.

  2008cites this paper
• Glioma stem cells: a midterm exam.

  2008cites this paper
• CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.

  2008cites this paper
• S6K1 plays a key role in glial transformation.

  2008cites this paper
• Characterization and transformation potential of “Synthetic” astrocytes differentiated from murine embryonic stem cells

  2008cites this paper
• treatmentastrocytic glioma: genetics, biology, and paths to

  2008cites this paper
• CSN 5 Isopeptidase Activity Links COP 9 Signalosome Activation to Breast Cancer Progression

  2008cites this paper
• Retinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression

  2008cites this paper
• Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.

  2007cites this paper
• Malignant astrocytic glioma : genetics , biology , and paths to treatment

  2007influential citation
• Primary Neurological Tumors

  2007cites this paper
• From Bread to Bedside: What Budding Yeast has Taught us about the Immortalization of Cancer Cells

  2007cites this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cites this paper
• Modeling the Initiation and Progression of Human Acute Leukemia in Mice

  2007cites this paper
• AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.

  2006cites this paper
• In Vitro Transformation Models: Modeling Human Cancer

  2006cites this paper
• Analysis of Ras transformation of human thyroid epithelial cells.

  2006cites this paper
• A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.

  2006cites this paper
• THE DARWINIAN PARADIGM OF TUMOR PROGRESSION

  2006cites this paper
• Comparison of the Effects of Ras Effector Mutants and Ras Effectors on Transformed and Tumorigenic Growth of Human and Rodent Cells

  2006cites this paper
• Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.

  2006cites this paper
• PI3-Kinase, PKB/Akt, mTOR, and Internal Signaling Pathways

  2006cites this paper
• ANTI-RAS STRATEGIES FOR CANCER TREATMENT

  2006cites this paper
• Genetically Engineered Human Cancer Models Utilizing Mammalian Transgene Expression

  2006cites this paper
• Real‐time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer

  2006cites this paper
• Oncogenic Property of Acrogranin in Human Uterine Leiomyosarcoma: Direct Evidence of Genetic Contribution in In vivo Tumorigenesis

  2006cites this paper
• Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme

  2006cites this paper
• Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts

  2006cites this paper
• Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

  2006cites this paper